BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38058849)

  • 1. Serum-free light chain test utilisation at a South African academic laboratory and comparison with serum protein electrophoresis results.
    Banderker RB; Fazel FB; Zemlin AE; Khine AA; Jalavu TP
    Afr J Lab Med; 2023; 12(1):2201. PubMed ID: 38058849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation of serum free light chains does not compensate for serum immunofixation only when screening for monoclonal gammopathies.
    Böer K; Deufel T
    Clin Chem Lab Med; 2009; 47(9):1109-15. PubMed ID: 19728853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum free light chains in clinical laboratory diagnostics.
    Jenner E
    Clin Chim Acta; 2014 Jan; 427():15-20. PubMed ID: 23999048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Free Light Chain Assay and κ/λ Ratio Performance in Patients Without Monoclonal Gammopathies:  High False-Positive Rate.
    Singh G
    Am J Clin Pathol; 2016 Aug; 146(2):207-14. PubMed ID: 27473738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of serum-free light-chain levels with markers of renal function.
    Erdem BK; Davran F; Yilmaz VT; Çetinkaya R; Akbas H
    Ren Fail; 2015 Jul; 37(6):1057-60. PubMed ID: 26056734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a new free light chain ELISA assay: bringing coherence with electrophoretic methods.
    Jacobs JFM; de Kat Angelino CM; Brouwers HMLM; Croockewit SA; Joosten I; van der Molen RG
    Clin Chem Lab Med; 2018 Jan; 56(2):312-322. PubMed ID: 28771430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Study on Free Light Chain Assay and Serum Immunofixation Electrophoresis for the Diagnosis of Monoclonal Gammopathies.
    Kuriakose E; Narayanan Unni Cheppayil S; Kuzhikandathil Narayanan S; Vasudevan A
    Indian J Clin Biochem; 2019 Jan; 34(1):76-81. PubMed ID: 30728676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays.
    Katzmann JA; Dispenzieri A; Kyle RA; Snyder MR; Plevak MF; Larson DR; Abraham RS; Lust JA; Melton LJ; Rajkumar SV
    Mayo Clin Proc; 2006 Dec; 81(12):1575-8. PubMed ID: 17165636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum immunoglobulin free light chain and heavy/light chain measurements in POEMS syndrome.
    Wang C; Su W; Zhang W; Di Q; Duan MH; Ji W; Cao XX; Zhou DB; Li J
    Ann Hematol; 2014 Jul; 93(7):1201-6. PubMed ID: 24482101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Serum Free Light Chain in Diagnosis and Monitoring of Plasma Cell Disorders.
    Ansari AA; Tipu HN; Ahmed D; Farhan M
    Crit Rev Immunol; 2019; 39(3):203-210. PubMed ID: 32421964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defect in Automated Antigen Excess Detection Discovered after Reviewing Serum Free Light Chain Results in Context with Clinical Findings.
    Lao KM; Pokharel A; Elzieny MMMI; Sykes E; Truscott SM
    Lab Med; 2024 Jan; 55(1):106-108. PubMed ID: 37285521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Audit of the Prevalence of Noncorrelation of Immunofixation with Protein Electrophoresis and Serum Free Light Chain Assays in Multiple Myeloma in a Tertiary Cancer Care Center.
    Paul C; Chakraborty S; Sugumar S; Bhattacharya R; Rath S; Chakraborty S
    Indian J Clin Biochem; 2021 Jul; 36(3):353-359. PubMed ID: 34220011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Free light chain and intact immunoglobulin abnormalities in heart transplant recipients: Two year follow-up timelines and clinical correlations.
    Sečník P; Lavríková P; Hošková L; Malíková P; Jabor A; Franeková J
    Transpl Immunol; 2017 Mar; 41():22-26. PubMed ID: 28167270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum free light chain assay reduces the need for serum and urine immunofixation electrophoresis in the evaluation of monoclonal gammopathy.
    Fulton RB; Fernando SL
    Ann Clin Biochem; 2009 Sep; 46(Pt 5):407-12. PubMed ID: 19641008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical Significance of Serum Free Light Chain in Monoclonal Gammopathy].
    Lu H; Zhang W
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):155-158. PubMed ID: 38387914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replacing urine protein electrophoresis with serum free light chain analysis as a first-line test for detecting plasma cell disorders offers increased diagnostic accuracy and potential health benefit to patients.
    McTaggart MP; Lindsay J; Kearney EM
    Am J Clin Pathol; 2013 Dec; 140(6):890-7. PubMed ID: 24225758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Free light chains assay: Indications and methods].
    Martellosio JP; Leleu X; Roblot P; Martin M; Puyade M
    Rev Med Interne; 2019 May; 40(5):297-305. PubMed ID: 30862366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Free Light Chain Assay and κ/λ Ratio: Performance in Patients With Monoclonal Gammopathy-High False Negative Rate for κ/λ Ratio.
    Singh G
    J Clin Med Res; 2017 Jan; 9(1):46-57. PubMed ID: 27924175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of serum free light chains in combination with protein electrophoresis and clinical information for diagnosing multiple myeloma in a general hospital population.
    Piehler AP; Gulbrandsen N; Kierulf P; Urdal P
    Clin Chem; 2008 Nov; 54(11):1823-30. PubMed ID: 18801937
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.